浊毒理论在化疗相关性腹泻中的应用探析

袁伟琛; 夏蕾; 张杰翔

doi:10.3969/j.issn.1671-038X.2022.10.14

浊毒理论在化疗相关性腹泻中的应用探析

- 1.
  山东中医药大学(济南，250355)
- 2.
  山东中医药大学附属医院肿瘤科
基金项目:
2021年度山东省医学会临床科研基金(No：YXH2022ZX02120)

详细信息

通讯作者: 夏蕾，E-mail：xialei0526@163.com

^Δ审校者

中图分类号: R273

收稿日期: 2022-07-03

刊出日期: 2022-10-15

Application of turbidity poison theory in chemotherapy-related diarrhea

- 1.
  Shandong University of Traditional Chinese Medicine, Jinan, 250355, China
- 2.
  Department of Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine

More Information

Corresponding author: XIA Lei, E-mail: xialei0526@163.com

Received Date: 03 July 2022

Publish Date: 15 October 2022

摘要

摘要: 浊为湿之极，毒为浊之盛，浊与毒常相兼致病。国医大师李佃贵教授创立的浊毒理论广泛应用于脾胃疾病中，疗效较佳。该文通过凝练浊毒理论，发现浊毒为化疗相关性腹泻发生、发展的核心病因病机，具体概括为脾虚湿盛、湿化为浊、浊邪夹杂痰饮和瘀血等病理产物热化为浊毒，浊毒又致脾肾虚衰。临床上以化浊解毒为治疗大法，依据化疗相关性腹泻的中医证型具体分为健脾化湿、调和肝脾、清热通腑与培补脾肾以化浊解毒，为化疗相关性腹泻的中医治疗提供了新的思路与借鉴。
- 浊毒理论 /
- 病因 /
- 病机 /
- 化疗相关性腹泻 /
- 化浊解毒
Abstract: Turbidity is the extreme of dampness, poison is the flourishing of turbidity, and turbidity and poison often combine to cause disease. Professor Li Diangui, a master of Traditional Chinese Medicine(TCM), founded the theory of turbid poison, which is widely used in diseases of the spleen and stomach, with better curative effect. By condensing the theory of turbidity poison, the author found that turbidity poison is the core etiology and pathogenesis of chemotherapy-related diarrhea(CID). Specifically summarized as spleen deficiency and dampness, dampness becomes turbid, turbid pathogens mixed with phlegm and blood stasis and other pathological products are heated into turbid poison, and turbid poison leads to spleen and kidney deficiency. Clinically, the treatment method is to remove turbidity and detoxification. According to the TCM syndromes of CID, it can be divided into spleen and dampness, harmonizing liver and spleen, clearing heat and dredging fu-organs, and nourishing spleen and kidney to remove turbidity and detoxify. This provides new ideas and references for TCM treatment of CID.
- turbidity poison theory /
- etiology /
- pathogenesis /
- chemotherapy-related diarrhea /
- turbid detoxification

HTML全文

参考文献(39)

[1]	Secombe KR, Coller JK, Gibson RJ, et al. The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicity[J]. Int J Cancer, 2019, 144(10): 2365-2376. doi: 10.1002/ijc.31836
[2]	张霞, 谢嵩. 预防用药在化疗所致不良反应中的作用调查分析[J]. 中国药房, 2011, 22(36): 3396-3398. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGYA201136021.htm
[3]	Andreyev J, Ross P, Donnellan C, et al. Guidance on the management of diarrhoea during cancer chemotherapy[J]. Lancet Oncol, 2014, 15(10): e447-e460. doi: 10.1016/S1470-2045(14)70006-3
[4]	Stein A, Voigt W, Jordan K. Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management[J]. Ther Adv Med Oncol, 2010, 2(1): 51-63. doi: 10.1177/1758834009355164
[5]	闫馨文, 刘洋洋, 常秀娟, 等. 化疗相关性腹泻[J]. 现代消化及介入诊疗, 2021, 26(4): 508-513. doi: 10.3969/j.issn.1672-2159.2021.04.023
[6]	Tao G, Huang J, Moorthy B, et al. Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity[J]. Expert Opin Drug Metab Toxicol, 2020, 16(11): 1109-1124. doi: 10.1080/17425255.2020.1815705
[7]	梁平, 王玉栋, 侯娟, 等. 奥曲肽防治肿瘤放化疗相关性腹泻的系统评价[J]. 肿瘤, 2015, 35(12): 1359-1367. doi: 10.3781/j.issn.1000-7431.2015.33.596
[8]	张新峰, 乔翠霞, 程旭锋, 等. 中西医结合治疗不同中医证型化疗相关性腹泻[J]. 中成药, 2015, 37(9): 1914-1916. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA201509009.htm
[9]	陈茜茹, 程志强. 中医药防治伊立替康所致迟发性腹泻概述[J]. 中华中医药杂志, 2018, 33(3): 1014-1017. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201803056.htm
[10]	吴存恩, 刘沈林, 壮雨雯, 等. 中医药治疗化疗相关性腹泻之优势探析[J]. 中华中医药学刊, 2016, 34(8): 1887-1889. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYHS201608027.htm
[11]	高宇, 胡少博, 邓超, 等. 基于中医传承计算平台探索中医药治疗化疗性腹泻用药配伍规律[J]. 海南医学院学报, 2022, 28(7): 544-549. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYY202207010.htm
[12]	王浩, 段佩雯, 王松坡. 中医药治疗肿瘤化疗相关性腹泻研究进展[J]. 山东中医杂志, 2019, 38(3): 295-298. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY201903024.htm
[13]	弓树德, 施义. 国医大师周仲瑛运用乌梅丸治疗食管癌化疗所致寒热错杂型腹泻经验浅析[J]. 浙江中医药大学学报, 2018, 42(4): 287-289. https://www.cnki.com.cn/Article/CJFDTOTAL-BHON201804008.htm
[14]	杨通通, 徐艺. 单兆伟教授治疗泄泻临证经验[J]. 浙江中医药大学学报, 2022, 46(5): 519-521, 526. https://www.cnki.com.cn/Article/CJFDTOTAL-BHON202205008.htm
[15]	邢玉瑞. 中医浊毒概念问题探讨[J]. 中医杂志, 2017, 58(14): 1171-1174. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201714001.htm
[16]	敖海清, 朱艳芳. "毒邪"的内涵及其致病特点[J]. 山东中医杂志, 2008(1): 5-6. doi: 10.3969/j.issn.0257-358X.2008.01.002
[17]	张惜燕, 邢玉瑞, 胡勇. 中医毒邪研究及相关问题探讨[J]. 陕西中医药大学学报, 2022, 45(1): 48-52. https://www.cnki.com.cn/Article/CJFDTOTAL-SXXY202201011.htm
[18]	刘宁, 赵进喜, 贾海忠, 等. 毒邪致病, 急危疑难; 从毒论治, 重在审因[J]. 环球中医药, 2021, 14(12): 2166-2169. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202112015.htm
[19]	赵雯红, 肖颖, 王文举, 等. 以人体微生态学诠释浊毒理论的内涵[J]. 中医杂志, 2018, 59(3): 185-190. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201803002.htm
[20]	徐伟超, 赵润元, 李佃贵, 等. 浊毒证充实中医证候学[J]. 中华中医药杂志, 2019, 34(10): 4580-4582. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201910031.htm
[21]	王宇阳, 马放, 占永立. 基于"浊毒"理论论治慢性肾脏病[J]. 中医杂志, 2019, 60(16): 1374-1377. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ201916007.htm
[22]	孙建慧, 杨倩, 张纨, 等. 脾虚浊毒论[J]. 北京中医药大学学报, 2021, 44(9): 812-817. https://www.cnki.com.cn/Article/CJFDTOTAL-JZYB202109008.htm
[23]	李佃贵. 从浊毒理论的建立与应用谈中医学创新与发展[J]. 中医杂志, 2020, 61(22): 1938-1940. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202022004.htm
[24]	张纨, 孙建慧, 李娅, 等. 国医大师李佃贵治疗溃疡性结肠炎经验[J]. 中华中医药杂志, 2019, 34(4): 1504-1506. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201904051.htm
[25]	赵润元, 谷诺诺, 白亚楠, 等. 李佃贵治疗慢性胃炎经验[J]. 中华中医药杂志, 2018, 33(7): 2910-2913. https://www.cnki.com.cn/Article/CJFDTOTAL-BXYY201807052.htm
[26]	王杰, 赵润元, 杜艳茹. 李佃贵教授治疗胃癌经验[J]. 时珍国医国药, 2018, 29(10): 2505-2506. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY201810073.htm
[27]	周仲瑛, 程海波, 周学平, 等. 中医药辨治肿瘤若干理念问题的探讨[J]. 南京中医药大学学报, 2014, 30(2): 101-104. https://www.cnki.com.cn/Article/CJFDTOTAL-NJZY201402002.htm
[28]	程海波, 李柳, 周学平, 等. 中医肿瘤癌毒病机辨证体系的创建[J]. 中医杂志, 2020, 61(20): 1767-1770. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202020006.htm
[29]	韩欣璞, 许博文, 李杰. 基于"寒气生浊"探讨胃癌微环境的微观辨治[J]. 中医杂志, 2022, 63(12): 1135-1138. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZYZ202212007.htm
[30]	王绍坡, 孙润雪, 刘小发, 等. 恶性肿瘤浊毒论[J]. 时珍国医国药, 2021, 32(12): 2985-2987. https://www.cnki.com.cn/Article/CJFDTOTAL-SZGY202112047.htm
[31]	庞淼, 徐凯, 庞德湘. 庞德湘教授治疗大肠癌化疗不良反应经验总结[J]. 浙江中医药大学学报, 2018, 42(12): 1016-1018, 1025. https://www.cnki.com.cn/Article/CJFDTOTAL-BHON201812010.htm
[32]	张传龙, 谭兆峰, 高梦琦, 等. 基于《伤寒论》虚寒下利论治化疗相关性腹泻[J]. 环球中医药, 2020, 13(11): 1942-1944. https://www.cnki.com.cn/Article/CJFDTOTAL-HQZY202011029.htm
[33]	陆菁菁, 刘沈林. 刘沈林治疗消化道肿瘤化疗后腹泻经验[J]. 中医肿瘤学杂志, 2021, 3(2): 80-84. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYZL202102019.htm
[34]	王辉, 吕金仓, 何华, 等. 李佃贵教授从浊毒论治腹泻型肠易激综合征经验[J]. 河北中医, 2014, 36(3): 329-331. https://www.cnki.com.cn/Article/CJFDTOTAL-HBZY201403003.htm
[35]	王晶, 刘小发, 刘梦凡, 等. 国医大师李佃贵诊治脾胃病经验[J]. 光明中医, 2022, 37(2): 220-222. https://www.cnki.com.cn/Article/CJFDTOTAL-GMZY202202015.htm
[36]	王红霞, 王威, 冀建斌, 等. 从"浊毒-微生态"理论探讨溃疡性结肠炎的病机及治疗[J]. 天津中医药, 2022, 39(6): 734-737. https://www.cnki.com.cn/Article/CJFDTOTAL-TJZY202206011.htm
[37]	娄莹莹, 李佃贵, 霍永利, 等. 溃疡性结肠炎特色病机"浊毒损膜伤络"及其意义[J]. 中国中西医结合杂志, 2022, 42(6): 749-753. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ202206019.htm
[38]	徐伟超, 李佃贵, 刘建平, 等. 浊毒理论创新中医病因病机学[J]. 中国中西医结合杂志, 2019, 39(8): 913-915. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZXJ201908011.htm
[39]	裴育莹, 贾立群. 伊立替康导致腹泻中医证型及用药规律分析[J]. 辽宁中医药大学学报, 2018, 20(12): 144-147. https://www.cnki.com.cn/Article/CJFDTOTAL-LZXB201812043.htm